M OZANIMOD (is an active metabolite) | OZANIMOD | ATC L04AA38
IMMUNOMODULATING SPHINGOSINE 1- PHOSPHATE RECEPTOR (SIP) MODULATOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) | - | Cmax 19.4 NANOMOLAR PPB 99.8 PERCENT HT 264 HOUR | SPHINGOSINE 1- PHOSPHATE RECEPTORS S1P 1 AND 5 | Sphingosine 1-phosphate receptor 1 agonist P21453 S1PR1_HUMAN | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |